Occupational Activity – Page 22 – Talk Bio

Actionable Insights Powered by AI

Pharmaceutical Industry Faces Widespread Layoffs Amid Economic Pressures

11 months ago talkbio0Tagged Biopharma, economic pressures, Industry, Pharmaceutical Layoffs, restructuring

pharmaceutical layoffs, economic pressures, biopharma industry, job cuts, restructuring efforts

Travere Therapeutics Pauses Phase 3 HARMONY Study Due to Manufacturing Scale-Up Challenges

11 months ago talkbio0Tagged Homocystinuria, Manufacture, Pegtibatinase, Phase 3 HARMONY Study, Problem, scale-up

Travere Therapeutics, Phase 3 HARMONY Study, Pegtibatinase, Classical Homocystinuria, Manufacturing Scale-Up Issue

Pfizer Generates $2.88 Billion by Selling Off Hundreds of Millions of Haleon Shares

12 months ago talkbio0Tagged Drug Industry, financial, Haleon, News [Publication Type], Pfizer, Sales - occupational activity

Pfizer, Haleon, share sale, pharmaceutical industry, financial news

Metsera and Amneal Collaborate on Next-Generation Obesity Medicines, with Leadership Transition at Metsera

12 months ago talkbio0Tagged Amneal, Leadership, Manufacture, Metsera, Obesity, Partnership, strategic collaboration, Transition Mutation

Metsera, Amneal, Obesity Drugs, Strategic Collaboration, Manufacturing Partnership, Leadership Transition

Prime Medicine Partners with Bristol Myers Squibb in $3.5B Cell Therapy Deal, Narrows Pipeline Focus

12 months ago talkbio0Tagged BMS, Burning Mouth Syndrome, Cell Therapy, Edit, ex vivo, Gene Modification, Ifosfamide/Methotrexate/Procarbazine protocol, PASSIGE, pipeline, Prime Medicine, Reprioritization, squibb, strategic collaboration, Technology

Prime Medicine, Bristol Myers Squibb (BMS), Cell Therapy, Gene Editing, Prime Editing, PASSIGE Technology, Ex Vivo T-Cell Therapies, Pipeline Reprioritization, Strategic Collaboration

Masimo Appoints Michelle Brennan as Interim CEO Following Joe Kiani’s Resignation

12 months ago talkbio0Tagged board of directors, Brennan, Capital Management, CEO, Kiani, Masimo, Michelle, Politan, resignation

Masimo, Joe Kiani, Michelle Brennan, Politan Capital Management, Interim CEO, Board of Directors, Resignation

AI Guidance for Investors: Navigating the Future with Strategic Approaches and Regulatory Insights

12 months ago talkbio0Tagged Adoption, Advice, Artificial Intelligence, Computer Security, governance, Health care facility, investors, Mapping Strategies, Regulatory Impact, Risk, Strategic AI

AI Guidance for Investors, Strategic AI Adoption, Regulatory Impact on AI, Cybersecurity Risks in AI, AI Mapping Strategies, Data Governance in AI, Future of AI in Healthcare

Telix Acquires RLS to Bolster Radiopharmaceutical Manufacturing and Distribution in North America

12 months ago talkbio0Tagged Acquisition (action), North America, production, radiometal, Radiopharmaceuticals, Restless Legs Syndrome, Social Networks, Spatial Distribution, Telix

Telix Pharmaceuticals, RLS (USA) Inc., radiopharmaceutical manufacturing, distribution, acquisition, North America, radiometal production network

Upstream Biotech Prepares to Join the Wave of Biotech IPOs with Inflammation-Focused Therapies

12 months ago talkbio0Tagged biotech, Biotechnology, healthcare innovation, Industry, Inflammation-Focused Therapies, IPOs, offerings, public entity, Upstream

Biotech IPOs, Upstream Biotech, Inflammation-focused therapies, Biotechnology industry, Public offerings, Healthcare innovation

Enhanced Manufacturing Efforts by Sanofi and AstraZeneca Aim to Prevent Beyfortus Shortfalls in 2024

12 months ago talkbio0Tagged AstraZeneca, Beyfortus, chain management, Manufacture, Monoclonal Antibodies, Respiratory syncytial virus, sanofi

Beyfortus, RSV prevention, monoclonal antibody, Sanofi, AstraZeneca, manufacturing efforts, supply chain management